{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:57:56Z","timestamp":1790927876557,"version":"4.1.0"},"reference-count":169,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>Information on new prescription drugs is increasingly complex and fragmented, posing challenges for healthcare professionals, patients, and payers. Clinicians require concise, actionable guidance to support prescribing decisions, while patients seek to balance benefits and harms when making decisions aligned with their treatment goals. Payers need comparative effectiveness data to inform coverage decisions that shape access and resource allocation. However, inadequacies in drug information communication often lead to overestimation of benefits and underestimation of harms. In this White Paper, we explore how information about newly approved drugs is generated, disseminated, and interpreted. We examine the information needs of healthcare professionals, patients, and payers and the influence of regulatory standards on available evidence. Focusing on regulated communication channels, such as prescription drug labeling, medication guides, and clinical trial snapshots, we highlight the foundational role of regulatory agencies in setting evidence standards and legitimizing drug information. We also consider alternative information sources, including pharmaceutical advertising, which coexist with regulated content. Against a backdrop of increasing uncertainty of drug approval evidence, we identify documented principles that regulators can adopt to meet drug information needs. Recommendations for improvements aim to better serve patients, support clinical decision making, and promote ethical healthcare resource allocation. While centered on the US context, the paper draws parallels with the European information landscape.<\/jats:p>","DOI":"10.1002\/cpt.70401","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T06:32:23Z","timestamp":1785047543000},"page":"855-870","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Navigating the Prescription Drug Information System"],"prefix":"10.1002","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3008-300X","authenticated-orcid":false,"given":"Irina V.","family":"Wang","sequence":"first","affiliation":[{"name":"Pharmaceutical Policy Lab, LSE Health The London School of Economics and Political Science  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Davis","sequence":"additional","affiliation":[{"name":"Pharmaceutical Policy Lab, LSE Health The London School of Economics and Political Science  London UK"},{"name":"Department of Global Health and Social Medicine King's College London  London UK"},{"name":"Lisa Schwartz Foundation for Truth in Medicine  Norwich Vermont USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Forrest","sequence":"additional","affiliation":[{"name":"Pharmaceutical Policy Lab, LSE Health The London School of Economics and Political Science  London UK"},{"name":"Department of Health Policy The London School of Economics and Political Science  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Cherla","sequence":"additional","affiliation":[{"name":"Pharmaceutical Policy Lab, LSE Health The London School of Economics and Political Science  London UK"},{"name":"Division of Health Policy and Insurance Research, Department of Population Medicine Harvard Medical School and Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4385-5773","authenticated-orcid":false,"given":"Maximilian","family":"Siebert","sequence":"additional","affiliation":[{"name":"Harvard\u2010MIT Center for Regulatory Science Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Cowden","sequence":"additional","affiliation":[{"name":"Patient Advocate  North Port\u2010Sarasota Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9205-1552","authenticated-orcid":false,"given":"Sophia","family":"Walker","sequence":"additional","affiliation":[{"name":"Patient Partner  Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-2230","authenticated-orcid":false,"given":"Tamar","family":"Krishnamurti","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine University of Pittsburgh  Pittsburgh Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7798-4560","authenticated-orcid":false,"given":"Florence T.","family":"Bourgeois","sequence":"additional","affiliation":[{"name":"Pharmaceutical Policy Lab, LSE Health The London School of Economics and Political Science  London UK"},{"name":"Harvard\u2010MIT Center for Regulatory Science Harvard Medical School  Boston Massachusetts USA"},{"name":"Computational Health Informatics Program Boston Children's Hospital  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Woloshin","sequence":"additional","affiliation":[{"name":"Pharmaceutical Policy Lab, LSE Health The London School of Economics and Political Science  London UK"},{"name":"Lisa Schwartz Foundation for Truth in Medicine  Norwich Vermont USA"},{"name":"The Dartmouth Institute for Health Policy and Clinical Practice  Hanover New Hampshire USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita K.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Pharmaceutical Policy Lab, LSE Health The London School of Economics and Political Science  London UK"},{"name":"Lisa Schwartz Foundation for Truth in Medicine  Norwich Vermont USA"},{"name":"Division of Health Policy and Insurance Research, Department of Population Medicine Harvard Medical School and Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7192-5751","authenticated-orcid":false,"given":"Huseyin","family":"Naci","sequence":"additional","affiliation":[{"name":"Pharmaceutical Policy Lab, LSE Health The London School of Economics and Political Science  London UK"},{"name":"Lisa Schwartz Foundation for Truth in Medicine  Norwich Vermont USA"},{"name":"Department of Health Policy The London School of Economics and Political Science  London UK"},{"name":"Division of Health Policy and Insurance Research, Department of Population Medicine Harvard Medical School and Harvard Pilgrim Health Care Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"e_1_2_11_1_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.368"},{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-05911-1"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081720"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2604-0"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.4793"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.6016"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1710755115"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.24926\/265535.1030"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(99)00376-7"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(96)00221-3"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.12480"},{"key":"e_1_2_11_12_1","volume-title":"Engaging Patients in Healthcare","author":"Coulter A.","year":"2011"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2614"},{"key":"e_1_2_11_14_1","unstructured":"Karlawish J.If you have Alzheimer's disease who will take part in your care?STAT News. February 9 2026 <https:\/\/www.statnews.com\/2026\/02\/09\/dementia\u2010who\u2010will\u2010take\u2010part\u2010in\u2010care\/>. Accessed May 5 2026."},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00294-4"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-025-02927-7"},{"key":"e_1_2_11_17_1","article-title":"Amyloid\u2010beta\u2010targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease","volume":"4","author":"Nonino F.","year":"2026","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7624"},{"key":"e_1_2_11_19_1","first-page":"115","article-title":"Information needs priorities in patients diagnosed with cancer: a systematic review","volume":"2014","author":"Tariman J.D.","year":"2014","journal-title":"J. Adv. Pract. Oncol."},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2004.06.006"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2013.03.011"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a752"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.2198"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-2-201107190-00005"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02328-1"},{"key":"e_1_2_11_27_1","unstructured":"Alzheimer's Disease Facts and Figures<https:\/\/www.alz.org\/alzheimers\u2010dementia\/facts\u2010figures> (2025)."},{"key":"e_1_2_11_28_1","first-page":"206","article-title":"A primer on formulary structures and strategies","volume":"30","author":"Hydery T.","year":"2024","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"e_1_2_11_29_1","unstructured":"Institute for Clinical and Economic Review<https:\/\/icer.org\/>. Accessed October 2 2025."},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30139-X"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.20288"},{"key":"e_1_2_11_32_1","first-page":"345","article-title":"The role of the FDA in innovation policy","volume":"13","author":"Eisenberg R.S.","year":"2007","journal-title":"Mich. Telecomm. Tech. Rev."},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1210007"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb2517623"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-020-00203-6"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1515\/9781400835119"},{"key":"e_1_2_11_37_1","first-page":"27093","article-title":"Providing clinical evidence of effectiveness for human drug and biological products","volume":"63","author":"FDA","year":"1998","journal-title":"Fed. Regist."},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5403"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282034"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3284"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01495-7"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.24406"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.5985"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-7-199610010-00011"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.1097"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.2829"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.4710"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7190"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.4175"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1680"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2025-001934"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1959"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01654"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2104846"},{"key":"e_1_2_11_55_1","unstructured":"Pazdur R.Regulatory decision to withdraw avastin (bevacizumab) firstline metastatic breast cancer indication<https:\/\/www.fda.gov\/media\/79525\/download> (2010)."},{"key":"e_1_2_11_56_1","volume-title":"Makena (Hydroxyprogesterone Caproate Injection) Information"},{"key":"e_1_2_11_57_1","volume-title":"FDA's Sentinel Initiative"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.0294"},{"key":"e_1_2_11_59_1","volume-title":"FDA's Labeling Resources for Human Prescription Drugs"},{"key":"e_1_2_11_60_1","volume-title":"What We Do"},{"key":"e_1_2_11_61_1","volume-title":"Communicating Risks and Benefits: An Evidence\u2010Based User's Guide","author":"Fischhoff B.","year":"2018"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2014.05.140039"},{"key":"e_1_2_11_63_1","first-page":"72063","article-title":"Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule","volume":"79","author":"Food and Drug Administration, HHS","year":"2014","journal-title":"Fed. Regist."},{"key":"e_1_2_11_64_1","unstructured":"Prescribers' Digital Reference<https:\/\/www.pdr.net\/>. Accessed May 5 2026."},{"key":"e_1_2_11_65_1","unstructured":"UpToDate: Trusted evidence\u2010based solutions for modern healthcare<https:\/\/www.wolterskluwer.com\/en\/solutions\/uptodate>. Accessed May 5 2026."},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073711"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2024.01134"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05460-2"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.3338"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0402"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.11.012"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100332"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00152-9"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101953"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.09.2842"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/CAT.24.0483"},{"key":"e_1_2_11_77_1","volume-title":"Patient\u2010Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Debcision\u2010Making"},{"key":"e_1_2_11_78_1","unstructured":"Gonzalez\u2010Quevedo R.Patient experience data in development programs and regulatory decision\u2010makingPresented at: ISG Meeting; June 30 European Medicines Agency <https:\/\/www.ema.europa.eu\/en\/documents\/presentation\/presentation\u2010patient\u2010experience\u2010data\u2010development\u2010programs\u2010regulatory\u2010decision\u2010making\u2010r\u2010gonzalez\u2010quevedo\u2010ema_en.pdf> (2025)."},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.13917"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.8121"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2023.00466"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1214646110"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0907708"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.05.022"},{"key":"e_1_2_11_85_1","volume-title":"Patient Medication Information (PMI)"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.4146"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.01050"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.00010"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2018.08.001"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02810"},{"key":"e_1_2_11_91_1","volume-title":"Research C for DE and Drug Trials Snapshots"},{"key":"e_1_2_11_92_1","unstructured":"Drug Trials Snapshots Drug trials snapshots: IMDELLTRA"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2789"},{"key":"e_1_2_11_94_1","volume-title":"Voranigo"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1700"},{"key":"e_1_2_11_96_1","article-title":"Biogen's Aduhelm faces more obstacles as some insurers balking at paying for drug","author":"Terry M.","journal-title":"BioSpace"},{"key":"e_1_2_11_97_1","article-title":"Alzheimer's patients are in limbo as hospitals, insurers grapple with whether to offer Aduhelm","author":"Joseph A.","journal-title":"STAT News"},{"key":"e_1_2_11_98_1","article-title":"\u2018Maisie's Army\u2019: how a grassroots group is mobilizing to help toddlers access a lifesaving drug","author":"Chakradhar S.","journal-title":"STAT News"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-012-2068-7"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3762"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0264"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066844"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1452"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.03.066"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.01.011"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.205"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.1122"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.6414"},{"key":"e_1_2_11_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33215"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0516"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304677"},{"key":"e_1_2_11_112_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6770"},{"key":"e_1_2_11_113_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1505"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-069115"},{"key":"e_1_2_11_115_1","article-title":"Industry sponsorship and research outcome","volume":"2","author":"Lundh A.","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_11_116_1","doi-asserted-by":"crossref","unstructured":"Carey C. Daly M.&Li J.Nothing for something: marketing cancer drugs to physicians increases prescribing without improving mortality(2024. National Bureau of Economic Research). NBER Working Paper.https:\/\/doi.org\/10.3386\/w32336.","DOI":"10.3386\/w32336"},{"key":"e_1_2_11_117_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016408"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175493"},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-022-00479-z"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2411-7"},{"key":"e_1_2_11_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2018.01.010"},{"key":"e_1_2_11_122_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1902811"},{"key":"e_1_2_11_123_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000352"},{"key":"e_1_2_11_124_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.19320"},{"key":"e_1_2_11_125_1","unstructured":"MediaRadar.Prescription Medications Media Spend Overview<https:\/\/drive.google.com\/file\/d\/10ZB7Iyqit0fYIr6bC0eUpENWIcGfHjDO\/view> (2025)."},{"key":"e_1_2_11_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06254-7"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.7306"},{"key":"e_1_2_11_128_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.5182"},{"key":"e_1_2_11_129_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.611"},{"key":"e_1_2_11_130_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2220"},{"key":"e_1_2_11_131_1","unstructured":"Bob Nina and Brian<https:\/\/www.ispot.tv\/ad\/T9ZL\/leqembi\u2010bob\u2010nina\u2010and\u2010brian>. (2025)."},{"key":"e_1_2_11_132_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.31110"},{"key":"e_1_2_11_133_1","unstructured":"FDA launches crackdown on deceptive drug advertising.FDA News Release. September 9 2025 <https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010launches\u2010crackdown\u2010deceptive\u2010drug\u2010advertising>."},{"key":"e_1_2_11_134_1","article-title":"9 answers to burning questions about pharmaceutical ads","author":"Jetelina A.S.K.","journal-title":"STAT"},{"key":"e_1_2_11_135_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.18.2400"},{"key":"e_1_2_11_136_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002819"},{"key":"e_1_2_11_137_1","doi-asserted-by":"publisher","DOI":"10.1111\/hir.12192"},{"key":"e_1_2_11_138_1","article-title":"Use of social Media in Health Communication: findings from the health information National Trends Survey 2013, 2014, and 2017","volume":"26","author":"Huo J.","year":"2019","journal-title":"Cancer Control J. Moffitt Cancer Cent."},{"key":"e_1_2_11_139_1","volume-title":"Bad Influence: How the Internet Hijacked our Health","author":"Cohen D.","year":"2026"},{"key":"e_1_2_11_140_1","unstructured":"Malik A.Ozempic celebrities and TikTok: a regulatory nightmare waiting to happen?Bill of Health <https:\/\/petrieflom.law.harvard.edu\/2025\/06\/26\/ozempic\u2010celebrities\u2010and\u2010tiktok\u2010a\u2010regulatory\u2010nightmare\u2010waiting\u2010to\u2010happen\/> (2025). Accessed October 9 2025."},{"key":"e_1_2_11_141_1","doi-asserted-by":"publisher","DOI":"10.1093\/jphsr\/rmae022"},{"key":"e_1_2_11_142_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.11026"},{"key":"e_1_2_11_143_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocae254"},{"key":"e_1_2_11_144_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000417"},{"key":"e_1_2_11_145_1","doi-asserted-by":"publisher","DOI":"10.31478\/201509a"},{"key":"e_1_2_11_146_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006013422206"},{"key":"e_1_2_11_147_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.52894.1"},{"key":"e_1_2_11_148_1","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgag099"},{"key":"e_1_2_11_149_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d8164"},{"key":"e_1_2_11_150_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7015"},{"key":"e_1_2_11_151_1","unstructured":"LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1 795 PARTICIPANTS WITH EARLY ALZHEIMER'S DISEASE. Eisai Global <https:\/\/www.eisai.com\/news\/2022\/news202271.html> (2022). Accessed May 5 2026."},{"key":"e_1_2_11_152_1","unstructured":"Mani R. Yasuda S.J. Buracchio T.&Dunn B.Summary Review Application 761269Orig1s000<https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/summary_review\/2023\/761269Orig1s000SumR.pdf> (2022)."},{"key":"e_1_2_11_153_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_2_11_154_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m7"},{"key":"e_1_2_11_155_1","article-title":"Commercial influence in health: from transparency to independence","author":"Moynihan R.","journal-title":"BMJ"},{"key":"e_1_2_11_156_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.23968"},{"key":"e_1_2_11_157_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2336"},{"key":"e_1_2_11_158_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2026.1652"},{"key":"e_1_2_11_159_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X07306786"},{"key":"e_1_2_11_160_1","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.181870"},{"key":"e_1_2_11_161_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1317504111"},{"key":"e_1_2_11_162_1","doi-asserted-by":"publisher","DOI":"10.2196\/62828"},{"key":"e_1_2_11_163_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-074068"},{"key":"e_1_2_11_164_1","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2022-300457"},{"key":"e_1_2_11_165_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2026.10555"},{"key":"e_1_2_11_166_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264463"},{"key":"e_1_2_11_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33178-2"},{"key":"e_1_2_11_168_1","volume-title":"Aduhelm (Aducanumab)"},{"key":"e_1_2_11_169_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.1039"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70401","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.70401","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:50:16Z","timestamp":1790927416000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.70401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":169,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1002\/cpt.70401"],"URL":"https:\/\/doi.org\/10.1002\/cpt.70401","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"2025-10-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}